Abstract
Secondary hyperparathyroidism occurs almost ubiquitously in the ESRD population. Renal transplant usually corrects secondary hyperparathyroidism; however, a small percentage of patients may develop tertiary hyperparathyroidism as early as 1-year post-transplant. There is currently a lack of evidence and guidelines for treating tertiary hyperparathyroidism, specifically regarding the use of calcimimetics versus parathyroidectomy. Conflicting evidence also exists regarding optimal timing for parathyroidectomy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evenepoel P, et al. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin Transpl. 2018;26(3):393–402. https://doi.org/10.1111/j.1399-0012.2011.01524.x.
Finnerty BM, et al. Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. J Surgery. 2019;165:129–34. https://doi.org/10.1016/j.surg.2018.04.090.
Littbarski SA, Kaltenborn A, Gwiasda J, et al. Timing of parathyroidectomy in kidney transplant candidates with early secondary hyperparathyroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. J Surgery. 2018;163:373–80. https://doi.org/10.1016/j.surg.2017.10.016.
Dream S, Chen H, Lindeman B. Tertiary hyperparathyroidism why the delay? Ann Surg Open. 2020;273(3):120–2. https://doi.org/10.1097/SLA.0000000000004069.
Giollo Rivelli G, Lopes de Lima M, Mazzali M. Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy. J Bras Nefrol. 2020;42(3):315–22. https://doi.org/10.1590/2175-8239-JBN-2019-0207.
Okada M, Hiramitsu T, Ichimori T, et al. Comparison of pre- and post-transplant parathyroidectomy in renal transplant recipients and the impact of parathyroidectomy timing on calcium metabolism and renal allograft function: a retrospective single-center analysis. World J Surg. 2020;44:498–507. https://doi.org/10.1007/s00267-019-05124-6.
Meng C, Martins P, Frazao J, Pestana M. Parathyroidectomy in persistent post-transplantation hyperparathyroidism—single-center experience. Transplant Proc. 2017;49:795–8. https://doi.org/10.1016/j.transproceed.2017.01.067.
Delos Santos R, Rossi A, Coyne D, Maw TT. Management of post-transplant hyperparathyroidism and bone disease. Drugs. 2019;79:501–13. https://doi.org/10.1007/s40265-019-01074-4.
Patel R, Delos Santos R. The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism. J Bras Nefrol. 2020;42(3):264–5. https://doi.org/10.1590/2175-8239-JBN-2020-0107.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
M. Bloom reports employment with the University of Wisconsin Medical Foundation.
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bloom, M., Parajuli, S. (2022). Tertiary Hyperparathyroidism Post-Renal Transplant. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_62
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_62
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)